Last $4.20 USD
Change Today +0.02 / 0.48%
Volume 405.3K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David R. Savello Ph.D.

Senior Vice President of Development Operations, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 57 board members in 5 different organizations across 7 different industries.

See Board Relationships
67--

Background*

Dr. David R. Savello, Ph.D., also known as Dave, serves as the Senior Vice President of Development Operations of Xenoport, Inc. since November 2010. He also serves as the Executive Vice President and Chief Technology Officer at R.P. Scherer Inc. Prior to Xenoport, he served as Chief Executive Officer at NDA Partners, LLC, which he co-founded. Prior to this, Dr. Savello was Chief Scientific Officer and Senior Vice President of Research and Development at the Pharmaceutical ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

Former Director
2012-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee

Education*

MA
University of Maryland
MS
University of Maryland
PhD
University of Maryland
BS
Massachusetts College of Pharmacy and Health Sciences

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $4.20 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.